Omega-3 PUFAs as a Dietary Supplement in Senile Systemic Amyloidosis

2Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Eicosapentaenoic acid (EPA; 20:5) and docosahexaenoic acid (DHA; 22:6), two omega-3 poly-unsaturated fatty acids (PUFAs), are the main components in oil derived from fish and other marine organisms. EPA and DHA are commercially available as dietary supplements and are considered to be very safe and contribute to guaranteeing human health. Studies report that PUFAs have a role in contrasting neurodegenerative processes related to amyloidogenic proteins, such as β-amyloid for AD, α-synuclein in PD, and transthyretin (TTR) in TTR amyloidosis. In this context, we investigated if EPA and DHA can interact directly with TTR, binding inside the thyroxin-binding pockets (T4BP) that contribute to the tetramer stabilization. The data obtained showed that EPA and DHA can contribute to stabilizing the TTR tetramer through interactions with T4BP.

Cite

CITATION STYLE

APA

Ciccone, L., Nencetti, S., Rossello, A., Barlettani, L., Tonali, N., Nieri, P., & Orlandini, E. (2023). Omega-3 PUFAs as a Dietary Supplement in Senile Systemic Amyloidosis. Nutrients, 15(3). https://doi.org/10.3390/nu15030749

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free